Skip Navigation LinksCore Service > Lab Test Directory > Molecular Diagnostics > Molecular Diagnostics Overview

Molecular Diagnostics Overview

Image result for dna technology

Service

The Molecular Diagnostics department at the Royal Surrey County Hospital has been providing a Molecular testing service to a network of Hospitals since 2002. It currently serves 5 district general Hospitals in the South East of England: Royal Surrey County Hospital, Frimley Health (Frimley Park Hospital and Wexham Park Hospital), Ashford and St.Peter's and the Royal Berkshire.

The Department provides services that assist in the diagnosis, prognosis and therapy treatment decisions for numerous users including clinicians from oncology, haematology, biochemistry and microbiology. The oncology service is particularly vital in assisting clinicians to make informed decisions for therapeutic options.


People 

The molecular department is a small, friendly team of six people who have a passion for all things molecular as well as a fundamental belief that every step of the process should be performed to highest possible quality in order to deliver the most appropriate and reliable result every time.  

Technology 

State-of-the-art technology is used to provide the most accurate testing possible. For example, oncology patients have access to the same technologies here at RSCH as those being offered in the most renowned cancer centres in the world. Technologies are re-evaluated on a regular basis and the department is always looking for ways to improve the current service.

Image result for S5 ngs

Training, Future Directions and Partnerships

The department regularly offer work experience opportunities to graduate and post-graduate students and other members of staff for further molecular training and project-based work. There are many exciting projects under development and lined up for the next 12-24 months that will make a positive impact on patients' journeys through our hospitals. The development of partnerships with industry help our patients access the benefits of new technologies faster. 

This page was last updated by Bruno Ping on 19/NOV/2018